Cargando…
Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties
A series of novel pyrrolidin-2-one derivatives (17 compounds) with adrenolytic properties was evaluated for antiarrhythmic, electrocardiographic and antioxidant activity. Some of them displayed antiarrhythmic activity in barium chloride-induced arrhythmia and in the rat coronary artery ligation-repe...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016165/ https://www.ncbi.nlm.nih.gov/pubmed/20949258 http://dx.doi.org/10.1007/s00210-010-0566-x |
_version_ | 1782195681509769216 |
---|---|
author | Sapa, Jacek Nowaczyk, Alicja Kulig, Katarzyna |
author_facet | Sapa, Jacek Nowaczyk, Alicja Kulig, Katarzyna |
author_sort | Sapa, Jacek |
collection | PubMed |
description | A series of novel pyrrolidin-2-one derivatives (17 compounds) with adrenolytic properties was evaluated for antiarrhythmic, electrocardiographic and antioxidant activity. Some of them displayed antiarrhythmic activity in barium chloride-induced arrhythmia and in the rat coronary artery ligation-reperfusion model, and slightly decreased the heart rate, prolonged P–Q, Q–T intervals and QRS complex. Among them, compound EP-40 (1-[2-hydroxy-3-[4-[(2-hydroxyphenyl)piperazin-1-yl]propyl]pyrrolidin-2-one showed excellent antiarrhythmic activity. This compound had significantly antioxidant effect, too. The present results suggest that the antiarrhythmic effect of compound EP-40 is related to their adrenolytic and antioxidant properties. A biological activity prediction using the PASS software shows that compound EP-35 and EP-40 can be characterized by antiischemic activity; whereas, compound EP-68, EP-70, EP-71 could be good tachycardia agents. |
format | Text |
id | pubmed-3016165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-30161652011-02-04 Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties Sapa, Jacek Nowaczyk, Alicja Kulig, Katarzyna Naunyn Schmiedebergs Arch Pharmacol Original Article A series of novel pyrrolidin-2-one derivatives (17 compounds) with adrenolytic properties was evaluated for antiarrhythmic, electrocardiographic and antioxidant activity. Some of them displayed antiarrhythmic activity in barium chloride-induced arrhythmia and in the rat coronary artery ligation-reperfusion model, and slightly decreased the heart rate, prolonged P–Q, Q–T intervals and QRS complex. Among them, compound EP-40 (1-[2-hydroxy-3-[4-[(2-hydroxyphenyl)piperazin-1-yl]propyl]pyrrolidin-2-one showed excellent antiarrhythmic activity. This compound had significantly antioxidant effect, too. The present results suggest that the antiarrhythmic effect of compound EP-40 is related to their adrenolytic and antioxidant properties. A biological activity prediction using the PASS software shows that compound EP-35 and EP-40 can be characterized by antiischemic activity; whereas, compound EP-68, EP-70, EP-71 could be good tachycardia agents. Springer-Verlag 2010-10-15 2011 /pmc/articles/PMC3016165/ /pubmed/20949258 http://dx.doi.org/10.1007/s00210-010-0566-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Sapa, Jacek Nowaczyk, Alicja Kulig, Katarzyna Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
title | Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
title_full | Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
title_fullStr | Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
title_full_unstemmed | Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
title_short | Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
title_sort | antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016165/ https://www.ncbi.nlm.nih.gov/pubmed/20949258 http://dx.doi.org/10.1007/s00210-010-0566-x |
work_keys_str_mv | AT sapajacek antiarrhythmicandantioxidantactivityofnovelpyrrolidin2onederivativeswithadrenolyticproperties AT nowaczykalicja antiarrhythmicandantioxidantactivityofnovelpyrrolidin2onederivativeswithadrenolyticproperties AT kuligkatarzyna antiarrhythmicandantioxidantactivityofnovelpyrrolidin2onederivativeswithadrenolyticproperties |